WANY
GH icon

Wealthspire Advisors (New York)’s Guardant Health GH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$338K Sell
3,655
-231
-6% -$23.2K ﹤0.01% 689
2025
Q4 		$397K Buy
3,886
+235
+6% +$21K ﹤0.01% 694
2025
Q3 		$228K Buy
+3,651
New +$199K ﹤0.01% 753

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealthspire Advisors (New York)'s GH Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its Guardant Health (GH) stake by 5.9% in Q1 2026, selling an estimated $23.2K and leaving 3,655 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Wealthspire Advisors (New York) first reported a position in GH in Q3 2025 and has held it in 3 quarters since. The position peaked at $397K in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Wealthspire Advisors (New York) held 3,655 shares of Guardant Health worth $338K as of Q1 2026.
  • Wealthspire Advisors (New York) sold 231 Guardant Health shares in Q1 2026, an estimated $23.2K.
  • Guardant Health made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #689 holding.
  • Wealthspire Advisors (New York) first reported a position in Guardant Health in Q3 2025 and has held it in 3 quarters since.
  • Wealthspire Advisors (New York)'s Guardant Health position peaked at $397K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.